This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bracket Joins EPRO Consortium, A Program Of The Critical Path Institute

WAYNE, Pa., Feb. 28, 2012 /PRNewswire/ -- Bracket, a division of United BioSource Corporation (UBC), announced today a new collaboration that will seek to improve the quality of patient reported outcomes, a crucial element in the drug development process. Bracket has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, a program run by the Critical Path Institute (C-Path).

The ePRO Consortium is committed to advancing the quality, practicality, and acceptance of electronic data capture (EDC) methods used in clinical trials for PRO endpoint assessment. PROs provide the patients' perspectives of a medication or device during clinical trials and other clinical research studies.  PRO endpoints include quality of life, symptoms, functioning, cognition and general health status. 

Bracket will work with other members of the ePRO Consortium in a non-competitive, neutral environment to develop guidelines and advance the quality of electronic data collection methods for PROs.  The ePRO Consortium, which was formed in 2011, will collaborate with C-Path's PRO Consortium, a group of pharmaceutical companies working to improve PRO measurement for high priority therapeutic areas to help migrate the new PRO measures developed by the PRO Consortium to the appropriate electronic data capture format. The ePRO Consortium will also develop guidance on methodological considerations for PRO instrument migration and adaptation.

"Incorporating the patient perspective in innovation and using new technology, like ePRO, to do so in a scalable manner is crucial to expanding and enhancing all aspects of electronic patient reported outcomes," said Dr. Robert Epstein, United BioSource president.  "Partnering with the Critical Path Institute creates yet another venue for us to continue to advocate and innovate for the development of safe and effective drugs for patients."

C-Path is an independent non-profit institute created in 2005 by the University of Arizona and the U.S. Food and Drug Administration (FDA). Its neutral status allows C-Path to serve as an effective facilitator among scientists from the government, academia and the private sectors.  C-Path has forged key partnerships, created collaborations and helped build new working relationships among federal regulators and the pharmaceutical industry. Led by C-Path, scientists from academia, biotechnology companies, the government and pharmaceutical industry are working together to develop innovative new testing methods that enable life-saving drugs, devices and biological products to reach patients faster and with greater safety. 

Bracket is committed to leveraging the integration of science, technology and operational excellence to provide sponsors with unique, effective solutions to achieve greater precision and accurate outcomes in their clinical trials. Bracket utilizes a robust ePRO platform integrating IVRS, IWRS and CDR systems to efficiently collect complex data for global clinical trials. Bracket's user-friendly handheld solution is streamlining the way data are collected, transferred and managed to both simplify the process and improve data accuracy.  Bracket collaborates with UBC researchers on scientific issues related to e-PROs, including strategic guidance on and scientific implementation of study design, instrument development and validation, regulatory requirements and labeling claims. For more information about Bracket, please go to: www.bracketglobal.com.

About United BioSource CorporationUnited BioSource Corporation (UBC), a wholly owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS), is a global scientific and medical affairs organization that partners with life science companies to make medicine and medical products smarter for all stakeholders in the health care landscape.  UBC helps deliver authoritative, real-world evidence to characterize product effectiveness, address safety risk, and demonstrate value. UBC brings together recognized scientific and industry experts, research operations professionals, and new technologies to provide innovative solutions across the product lifecycle.  The company is headquartered in Chevy Chase, MD with offices in North and South America, Europe and Asia.  For more information about UBC, visit www.unitedbiosource.com.

SOURCE Bracket Global

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7870 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs